论文部分内容阅读
外科手术切除治疗肝细胞癌(hepatocellular carcinoma,HCC)虽可作为部分患者的首选治疗,但术后患者的5年复发率仍高达70%,5年生存率不足50%。对于复发性肝癌的治疗,国内外尚未达成共识。由于大多数复发性肝癌是直径小于3 cm的结节,射频消融(radiofrequency ablation,RFA)治疗能够达到与二次外科手术切除相似的结局,且具有创伤小、并发症少、术后恢复快、住院时间短等优点。本文对RFA治疗复发性小HCC进行讨论,以期为更好地治疗手术切除后复发的小HCC提供理论依据。
Surgical resection of hepatocellular carcinoma (HCC) may be the first choice for some patients, but the 5-year recurrence rate remains as high as 70% and the 5-year survival rate is less than 50%. For the treatment of recurrent liver cancer, no consensus has been reached at home and abroad. Since most recurrent HCCs are nodules less than 3 cm in diameter, radiofrequency ablation (RFA) treatment can achieve similar outcomes as secondary surgical resections with less trauma, fewer complications, faster postoperative recovery, Shorter hospital stay and so on. This article discusses the treatment of recurrent small HCC RFA, in order to provide a theoretical basis for better treatment of small HCC recurrence after resection.